Ferryx Shortlisted For HealthTech Award

Ferryx, an investee company within the Deepbridge Life Sciences EIS fund, has been shortlisted for the HealthTech Award at the Tech South West Awards 2023.

With a record 350 entries, over 40 judges were involved in the selection process, culminating in a full day at Clockwise Exeter to agree the final shortlists and winners. Now in their fifth year, the awards celebrate the best in tech from across the South West of England including Bath, Bristol, Cornwall and the Isles of Scilly, Devon, Dorset, Gloucestershire, Somerset and Wiltshire.

Formed in 2019 as a spin-out from the University of Bristol to take anti-inflammatory bacterial products into commercial production for the benefit of humans and animals., Ferryx's proprietary bacterial products can be developed as food supplements or prescription therapeutics and will be licensed to marketing and distribution partners for market entry.  

Listen to Episode 23 of the Deepbridge Discovery Podcast that features Jenny Bailey (Chief Executive Officer and Co-Founder of Ferryx) to discuss how Ferryx came to be, her background before setting up Ferryx, the challenges she has faced and the next steps and goals for Ferryx, by clicking here.